FDA-approved drug shows promise in lab models for blinding childhood disease

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

03/29/2023 07:45 AM EDT

Strategy may speed delivery of therapeutic options relative to time it would take to develop gene therapies.